Experience of Using Remdesivir in Patients with Novel Coronavirus Infection

• Egile Nagusiak: V. I. Petrov (Egilea), A. Yu. Ryazanova (Egilea), N. S. Privaltseva (Egilea), D. A. Nekrasov (Egilea)
• Formatua: Liburua
• Argitaratua: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products», 2022-12-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Timely, effective, and safe antiviral therapy in COVID-19 patients reduces complications, disability and mortality rates. The greatest concern with remdesivir is the risk of drug-induced liver injury, including in patients whose liver function is compromised by COVID-19.The aim of the study was to i...